Last updated: April 2026
Ro.co vs Dr. House: Compare GLP-1 Programs & Pricing
Side-by-side Ro.coand Dr. House: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Ro.co and Dr. House are two established telehealth providers offering GLP-1–based weight management programs. This article compares Ro.co vs Dr. House to help you identify which best fits your goals and preferences.
Ro.co vs Dr. House: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Ro.co | Brand med access (Code: ) | $145.00 — Yes | ||
| Dr. House | (Code: ) | — No |
Ro.co vs Dr. House: Medical Process & Accessibility
Ro.co focuses on a rapid telehealth intake, a streamlined questionnaire, and clinician approval within 24‑48 hours. After approval, a licensed pharmacist compounds the GLP‑1 medication and ships it directly to your door. Dr. House follows a slightly more structured pathway: an initial tele‑visit, a baseline labs order (often done through a partner lab), and a scheduled follow‑up every 4‑6 weeks to fine‑tune dosing. Both platforms operate entirely online and are compliant with FDA regulations for compounded medications.
Ro.co vs Dr. House: Pricing Comparison
Ro.co starts semaglutide at and tirzepatide at , while Dr. House begins at and . Because specific dollar amounts are not publicly disclosed, prospective patients should contact each provider for a detailed quote. Bold lower prices when they become available for easy visual comparison.
Both companies advertise introductory discounts. Ro.co offers a “Brand med access” promotion (no code required) that reduces the first month’s cost. Dr. House currently lists no active promo, but a future discount may be announced on their website.
Membership fees also differ: Ro.co charges a $145.00 monthly membership that grants access to ongoing clinician support, while Dr. House does not require a membership fee, positioning its costs as purely medication‑based.
Ro.co vs Dr. House: Clinical Oversight & Support
Both providers supply direct access to U.S.-licensed clinicians who evaluate medical history, confirm suitability for GLP‑1 therapy, and write the prescription. Ro.co’s model is designed for patients who want quick approval and minimal paperwork. Dr. House, on the other hand, emphasizes a more personalized relationship, offering detailed dose‑adjustment plans, nutrition counseling, and regular virtual check‑ins.
Book a Consultation with Ro.co
Ro.co vs Dr. House: Medication Quality & Safety
Each platform dispenses compounded GLP‑1 medications from accredited U.S. pharmacies that follow USP Chapter 795 standards for sterile compounding. While the products are not the brand‑name Wegovy® or Mounjaro®, they contain the same active ingredients (semaglutide or tirzepatide) and are FDA‑compliant when prescribed by a qualified clinician. Both providers require a valid prescription and verify patient identity before shipment.
Ro.co vs Dr. House: Customer Experience
Customer reviews consistently highlight Ro.co’s affordability and the speed of delivery—most users receive their medication within 5‑7 business days after approval. Dr. House receives praise for thorough medical support, with many patients noting the value of ongoing dose optimization and the ability to discuss side‑effects in real time.
Ro.co vs Dr. House: Final Verdict
If you prioritize a low‑cost entry point, a simple membership structure, and fast onboarding, Ro.co may be the better fit. If you desire more hands‑on clinical guidance, no membership fee, and a program that emphasizes regular monitoring, Dr. House could align better with your expectations. Both are reputable, licensed telehealth services that make GLP‑1 therapy accessible across the United States.
Join Ro.co
Get Started with Dr. House
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Recommended next step
Review the latest provider details before you decide.